Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Importers Notice of Application - 2014

Importers Notice of Application - 2014

Fisher Clinical Services, Inc. (October 8, 2014)

Cerilliant Corporation (October 7, 2014)

Chattem Chemicals, Inc. (October 7, 2014)

Fisher Clinical Services, Inc. (September 4, 2014)

Cody Laboratories, Inc. (September 4, 2014)

Catalent CTS, LLC; Correction (August 25, 2014)

United States Pharmacopeial Convention (August 20, 2014)

Research Triangle Institute (July 11, 2014)

Catalent CTS, LLC (June 17, 2014)

Alkermes Gainesville LLC (June 17, 2014)

Meda Pharmaceuticals, Inc. (June 17, 2014)

Actavis Pharma, Inc. (June 4, 2014)

Penick Corporation (June 4, 2014)

Mylan Technologies, Inc. (June 4, 2014)

Akorn, Inc. (June 4, 2014)

Rhodes Technologies (June 4, 2014)

Arizona Department of Corrections (June 4, 2014)

Wildlife Laboratories, Inc. (June 4, 2014)

R & D Systems, Inc. (June 4, 2014)

SA INTL GMBH C/O., Sigma Aldrich Co., LLC. (June 4, 2014)

Alltech Associates, Inc. (June 3, 2014)

Stepan Company (May 15, 2014)

Research Triangle Institute (April 28, 2014)

Almac Clinical Services, Inc., (ACSI) (April 28, 2014)

Meridian Medical Technologies (April 28, 2014)

Catalent CTS, Inc. (February 7, 2014)

S & B Pharma, Inc. (February 4, 2014)

Noramco, Inc. (January 22, 2014)

Siegfried USA, LLC. (January 10, 2014)

Myoderm (January 10, 2014)

Cody Laboratories, Inc. (January 10, 2014)

Fresenius Kabi USA, LLC. (January 10, 2014)

Hospira (January 2, 2014)

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility